KOREA WHO
-
-
-
CEO of Boryung
Jay Kim
Young Third-Generation Owner in Pharma Industry, Aggressively Investing in Space Healthcare
-
Last Updated on Nov 13, 2024
-
CEO of Boryung
Life Summary
Jay Kim (Korean name: Kim Jeong-gyun) is the President and CEO of Boryung (formerly known as Boryung Pharmaceutical). He also serves as the CEO of Boryung Holdings, the largest shareholder of Boryung.
He is a third-generation leader of the Boryung Group, following in the footsteps of the group’s founder Kim Seung-ho and Boryung Holdings Chairperson Kim Eun-sun.
His birth name was Yoo Jeong-gyun, but after his father passed away and his mother, Chairperson Kim Eun-sun, assumed management control, he changed his surname to Kim in 2010.
He has been injecting substantial capital into Boryung and is pursuing an ambitious mid- to long-term strategy with the goal of achieving KRW 1 trillion (US$ 721.4 million) in sales by 2026.
Born on August 29, 1985.
He graduated with a degree in Industrial Engineering from the University of Michigan and obtained a master’s degree in Social and Administrative Pharmacy from Chung-Ang University’s Graduate School of Medicine and Food.
He worked at Samjeong KPMG in the United States before joining Boryung Pharmaceutical’s Strategic Planning Office in November 2013 as an Executive Director.
In 2019, he was appointed CEO of Boryung Holdings, and in 2022, he also took on the role of President and CEO of Boryung, leading the company’s operations.
He is actively investing in new business ventures, including space healthcare.
#Boryung #JayKim #CEO #Pharmaceuticals #BoryungHoldings #KoreanBusiness #SpaceHealthcare #ThirdGenerationLeader #HealthcareInvestment #KimEunSun
He is a third-generation leader of the Boryung Group, following in the footsteps of the group’s founder Kim Seung-ho and Boryung Holdings Chairperson Kim Eun-sun.
His birth name was Yoo Jeong-gyun, but after his father passed away and his mother, Chairperson Kim Eun-sun, assumed management control, he changed his surname to Kim in 2010.
He has been injecting substantial capital into Boryung and is pursuing an ambitious mid- to long-term strategy with the goal of achieving KRW 1 trillion (US$ 721.4 million) in sales by 2026.
Born on August 29, 1985.
He graduated with a degree in Industrial Engineering from the University of Michigan and obtained a master’s degree in Social and Administrative Pharmacy from Chung-Ang University’s Graduate School of Medicine and Food.
He worked at Samjeong KPMG in the United States before joining Boryung Pharmaceutical’s Strategic Planning Office in November 2013 as an Executive Director.
In 2019, he was appointed CEO of Boryung Holdings, and in 2022, he also took on the role of President and CEO of Boryung, leading the company’s operations.
He is actively investing in new business ventures, including space healthcare.
#Boryung #JayKim #CEO #Pharmaceuticals #BoryungHoldings #KoreanBusiness #SpaceHealthcare #ThirdGenerationLeader #HealthcareInvestment #KimEunSun